Dl-Phenylalanine

Dl-Phenylalanine

SCHEMBL4862934

NC(Cc1ccccc1)C(=O)O.NCC(=O)O.NCC(=O)O

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Dl-Phenylalanine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 known ✓ P0DMS8 1/20 0.51
▸ SLC7A5 Q01650 4/20 0.85
▸ PTGS1 P23219 2/20 0.85
▸ ALPI P09923 1/20 0.85
▸ PKM P14618 1/20 0.85
▸ XIAP P98170 1/20 0.85
▸ SLC1A3 P43003 2/20 0.61
▸ SLC1A2 P43004 2/20 0.61
▸ SLC1A1 P43005 2/20 0.61
▸ SLC15A1 P46059 1/20 0.61
▸ LTA4H P09960 1/20 0.57
▸ CYP1A2 P05177 1/20 0.53
▸ GRIA2 P42262 1/20 0.53
▸ CPA1 P15085 2/20 0.52
▸ CPB1 P15086 1/20 0.52
▸ CPA3 P15088 1/20 0.52
▸ CPB2 Q96IY4 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.51
▸ USP2 O75604 1/20 0.51
▸ EGFR P00533 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Phenylalanine SCHEMBL1637917 1.00 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL1011892 1.00 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
D-Phenylalanine SCHEMBL1537448 1.00 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL3496164 1.00 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL2679075 1.00 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
Dl-Phenylalanine SCHEMBL9650016 1.00 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL1675272 1.00 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL218898 1.00 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
Dl-Phenylalanine SCHEMBL21816915 1.00 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
Dl-Phenylalanine SCHEMBL27579186 1.00 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357807-A1 CATALYTICALLY ACTIVE PROTEIN FOAMS, AND METHOD FOR PRODUCING SAME KARLSRUHER INSTITUT FUER TECHNOLOGIE (DE) 2023-11-09 — — US disclosed
EP-4188942-A1 CATALYTICALLY ACTIVE PROTEIN FOAMS, AND METHOD FOR PRODUCING SAME Karlsruher Institut für Technologie (DE) 2023-06-07 — — EP disclosed
US-7321022-B2 Electrostatic layer-by-layer self assembly; exposing film to an oxidizing or reducing agent; alternating layers of oppositely charged polypeptides; 1st layer polypeptide contains sulfhydryl-containing amino acid; 2nd layer polypeptide has two amino acid sequences joined by a glycine a proline linker. LOUISIANA TECH UNIVERSITY FOUNDATION, INC. (US) 2008-01-22 — — US disclosed
US-20070077275-A1 Multilayer films, coatings, and microcapsules comprising polypeptides LOUISIANA TECH UNIVERSITY FOUNDATION, INC. 2007-04-05 — — US disclosed
US-20060147543-A1 Method for controlling stability of nanofabricated polypeptide multilayer films, coatings, and microcapsules HAYNIE DONALD T 2006-07-06 — — US disclosed
US-6066462-A ADDING BIOTINYLATED PEPTIDE SUBSTRATE TO SOLUTION CONTAINING SELECTED ENZYME, INCUBATING TO FORM PHOSPHORYLATED PRODUCT, BINDING PRODUCT TO BIOTIN-BINDING MATRIX, DETECTING THE PRODUCT AND THUS MEASURING THE ACTIVITY OF ENZYME PROMEGA CORPORATION (US) 2000-05-23 — — US disclosed
US-5981580-A IN WHICH THE CARBOXY-TERMINUS HAS BEEN MODIFIED TO FORM VARIOUS AMIDES, ESTERS, KETONES, ALCOHOLS, ALCOHOL ESTERS AND NITRITES THEREOF, AND ARE USEFUL AS SUBSTRATES FOR N-MYRISTOYLTRANSFERASE (NMT) AND/OR ITS ACYL COENZYME G. D. SEARLE & CO. (US) 1999-11-09 — — US disclosed
WO-1999050229-A1 FATTY ACID ANALOGS AND PRODRUGS G.D. SEARLE & CO. (US) 1999-10-07 — — WO disclosed
US-5545718-A Synthetic peptides of the conjugate of ubiquitine and H2A histone PASTEUR SANOFI DIAGNOSTICS (FR) 1996-08-13 — — US disclosed
US-5427958-A Detecting presence of autoantibodies in biological fluids; forming peptide complexes; in vitro; diagnosing lupus, autoimmune diseases PASTEUR SANOFI DIAGNOSTICS (FR) 1995-06-27 — — US disclosed
US-5057495-A Hypotensive agents, diuretics QUEEN'S UNIVERSITY AT KINGSTON (CA) 1991-10-15 — — US disclosed
EP-0423301-A1 SYNTHETIC PEPTIDES OF THE CONJUGATE OF UBIQUITINE AND HISTONE H2A. NEOSYSTEM SA (FR) 1991-04-24 — — EP disclosed
WO-1990012806-A1 SYNTHETIC PEPTIDES OF THE CONJUGATE OF UBIQUITINE AND HISTONE H2A NEOSYSTEM S.A. (FR) 1990-11-01 — — WO disclosed
Send feedback